359 related articles for article (PubMed ID: 12614743)
1. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
2. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Jpn J Ophthalmol; 2002; 46(5):563-7. PubMed ID: 12457917
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy.
Nagayama Y; Izumi M; Kiriyama T; Yokoyama N; Morita S; Kakezono F; Ohtakara S; Morimoto I; Okamoto S; Nagataki S
Acta Endocrinol (Copenh); 1987 Dec; 116(4):513-8. PubMed ID: 3321820
[TBL] [Abstract][Full Text] [Related]
6. Relationships of orbital computed tomographic findings and activity scores to the prognosis of corticosteroid therapy in patients with Graves' ophthalmopathy.
Chang TC; Huang KM; Hsiao YL; Tzeng SS; Kao SC
Acta Ophthalmol Scand; 1997 Jun; 75(3):301-4. PubMed ID: 9253980
[TBL] [Abstract][Full Text] [Related]
7. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
[TBL] [Abstract][Full Text] [Related]
8. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
Koshiyama H; Koh T; Fujiwara K; Hayakawa K; Shimbo S; Misaki T
Thyroid; 1994; 4(4):409-13. PubMed ID: 7711503
[TBL] [Abstract][Full Text] [Related]
9. Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.
Higashiyama T; Nishida Y; Ohji M
Jpn J Ophthalmol; 2015 Nov; 59(6):430-5. PubMed ID: 26321629
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
[TBL] [Abstract][Full Text] [Related]
11. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.
Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N
Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498
[TBL] [Abstract][Full Text] [Related]
12. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
De Bellis A; Bizzarro A; Conte M; Coronella C; Solimeno S; Perrino S; Sansone D; Guaglione M; Wall JR; Bellastella A
Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
14. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
[TBL] [Abstract][Full Text] [Related]
15. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.
Erickson BA; Harris GJ; Lewandowski MF; Murray KJ; Massaro BM
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):651-60. PubMed ID: 7852132
[TBL] [Abstract][Full Text] [Related]
16. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Lepri A; Pinchera A
J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2020 Apr; 127(4S):S160-S171. PubMed ID: 32200817
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
Brauer VF; Scholz GH
Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
[TBL] [Abstract][Full Text] [Related]
19. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
Macchia PE; Bagattini M; Lupoli G; Vitale M; Vitale G; Fenzi G
J Endocrinol Invest; 2001 Mar; 24(3):152-8. PubMed ID: 11314743
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
Petersen IA; Kriss JP; McDougall IR; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
